KAPLAN M H, SVEC K H
J Exp Med. 1964 Apr 1;119(4):651-66. doi: 10.1084/jem.119.4.651.
Sera from patients with recent streptococcal infection or non-suppurative sequelae exhibit with variable frequency a precipitin reaction in agar gel with a partially purified streptococcal antigen which has been shown previously to be immunologically related to human heart tissue. This precipitin could be absorbed from sera with normal human heart tissue homogenates but not with homogenates of other organs. Demonstration of this cross-reaction by heart absorption was found dependent both upon the serologic properties of individual sera and the nature or state of purification of the streptococcal product employed as test antigen. Evidence was obtained of a close association of heart-related and non-heart-related antigenic determinants in partially purified preparations of the streptococcal antigen by both gel diffusion and immunoelectrophoresis. On immunoelectrophoretic analysis, cross-reactive antigen exhibited a more rapid mobility toward the anode than M protein. It was destroyed by digestion with trypsin, pepsin, and chymotrypsin. Based on specific absorption tests with a Type 5 and Type 19 strain, the antigen was localized to cell walls and to a lesser extent to cell membranes of these strains. Precipitating activity related to cross-reactive antibody was localized to the immunoglobulin zone in immunoelectrophoresis. Reactive sera showed diminution or loss of serological activity following heat inactivation at 56 degrees C or after prolonged storage at 4 degrees C. Sera containing cross-reactive precipitating antibody exhibited an immunofluorescent reaction with sarcolemma of cardiac myofibers, which was inhibited by streptococcal cross-reactive antigen. By this inhibition test, the immunofluorescent reaction related to cross-reactive antibody could be distinguished from that due to other heart-reactive factors. Antibody to streptococcal cross-reactive antigen defined by precipitation-absorption tests was observed in 24 per cent of patients with recent history of uncomplicated streptococcal infection and in the majority of patients with acute rheumatic fever, rheumatic heart disease, or acute glomerulonephritis. It was observed rarely in patients with non-streptococcal related disease. These data provide evidence that induction of cross-reactive autoantibody to heart in certain individuals is associated with streptococcal infection.
近期有链球菌感染或非化脓性后遗症患者的血清,与一种部分纯化的链球菌抗原在琼脂凝胶中呈现沉淀反应的频率各不相同,该抗原先前已被证明在免疫学上与人心脏组织相关。这种沉淀素可被正常人心脏组织匀浆从血清中吸收,但不能被其他器官的匀浆吸收。通过心脏吸收证明这种交叉反应既取决于个体血清的血清学特性,也取决于用作试验抗原的链球菌产物的性质或纯化状态。通过凝胶扩散和免疫电泳,在链球菌抗原的部分纯化制剂中获得了与心脏相关和非心脏相关抗原决定簇密切相关的证据。在免疫电泳分析中,交叉反应抗原向阳极的迁移速度比M蛋白更快。它可被胰蛋白酶、胃蛋白酶和糜蛋白酶消化破坏。基于对5型和19型菌株的特异性吸收试验,该抗原定位于这些菌株的细胞壁,在较小程度上定位于细胞膜。与交叉反应抗体相关的沉淀活性在免疫电泳中定位于免疫球蛋白区。反应性血清在56℃热灭活或在4℃长期储存后,血清学活性降低或丧失。含有交叉反应沉淀抗体的血清与心肌纤维的肌膜呈现免疫荧光反应,该反应可被链球菌交叉反应抗原抑制。通过这种抑制试验,与交叉反应抗体相关的免疫荧光反应可与其他心脏反应性因子引起的反应区分开来。在近期有单纯链球菌感染病史的患者中,24%的患者以及大多数急性风湿热、风湿性心脏病或急性肾小球肾炎患者中,观察到通过沉淀吸收试验确定的针对链球菌交叉反应抗原的抗体。在非链球菌相关疾病患者中很少观察到这种抗体。这些数据提供了证据,表明在某些个体中诱导针对心脏的交叉反应自身抗体与链球菌感染有关。